Biomedical · Investment · Legal · Publications
Biomedical Evidence Research
Evidence reviews of drug targets and therapeutic hypotheses, written for decision analysis.
Not medical advice. These pages summarise published research. They do not tell any individual whether to take a medicine.
Articles
PCSK9 as a target for lowering LDL cholesterol and cardiovascular risk
Research question: Does the published evidence support PCSK9 inhibition as a validated way to lower LDL cholesterol and reduce cardiovascular events, and where is that evidence weaker?
AI-assisted draft Last verified 2026-10-24
Earlier TAC Health Cards (April 2026, before ERF, without citations) remain available at /examples. They are not ERF articles.
How to read these articles
Every article uses the SYCDS Evidence Research Format (ERF): a research question, key findings, an evidence table with a check label on every claim, limitations, counterevidence, decision implications, what would change the assessment, and a dated update history.
- Abstract-checked checked against the published abstract or public record only.
- Partly verified checked through automated extraction from the full text, or through a secondary report; manual review pending.
- Inferred follows from other rows; no direct source.
- Overstated a source contradicts part of the claim.
- Interpretation a judgment, not a checkable fact.
No article is yet full-text-checked or reviewed by an independent expert. Each article states its own research status.
SYCDS Research · Articles are AI-assisted drafts unless stated otherwise · Not medical, investment or legal advice · Tac Yang